Annals of Allergy Asthma & Immunology最新文献

筛选
英文 中文
Pediatric Asthma Impairment and Risk Questionnaire 儿童哮喘损害和风险问卷:一种复合控制工具的原理和发展。
IF 5.8 2区 医学
Annals of Allergy Asthma & Immunology Pub Date : 2025-02-01 DOI: 10.1016/j.anai.2024.11.021
Miguel J. Lanz MD , Bradley E. Chipps MD , Robert S. Zeiger MD, PhD , Leonard B. Bacharier MD , Theresa W. Guilbert MD , Kevin R. Murphy MD , Tonya Winders MBA , Acklema Mohammad MD , Monique LeNoir MA , Ileen Gilbert MD , James M. Eudicone MS, MBA , Karin S. Coyne PhD, MPH , Gale Harding MA , Maureen George PhD, RN
{"title":"Pediatric Asthma Impairment and Risk Questionnaire","authors":"Miguel J. Lanz MD ,&nbsp;Bradley E. Chipps MD ,&nbsp;Robert S. Zeiger MD, PhD ,&nbsp;Leonard B. Bacharier MD ,&nbsp;Theresa W. Guilbert MD ,&nbsp;Kevin R. Murphy MD ,&nbsp;Tonya Winders MBA ,&nbsp;Acklema Mohammad MD ,&nbsp;Monique LeNoir MA ,&nbsp;Ileen Gilbert MD ,&nbsp;James M. Eudicone MS, MBA ,&nbsp;Karin S. Coyne PhD, MPH ,&nbsp;Gale Harding MA ,&nbsp;Maureen George PhD, RN","doi":"10.1016/j.anai.2024.11.021","DOIUrl":"10.1016/j.anai.2024.11.021","url":null,"abstract":"<div><h3>Background</h3><div>Asthma in children is a leading cause of missed school days, emergency department visits, and hospitalizations. Approximately 40% of children with asthma experience uncontrolled disease and annual exacerbations. There is a need for a validated composite tool for children, such as the Asthma Impairment and Risk Questionnaire (AIRQ), which was developed to assess current control and predict exacerbations in adolescents and adults with asthma.</div></div><div><h3>Objective</h3><div>To obtain feedback from children with asthma and their parents/caregivers to inform development of a version of the AIRQ for pediatric use (Peds-AIRQ).</div></div><div><h3>Methods</h3><div>Children with asthma aged 5 to 11 years and their parents/caregivers participated in cognitive interviews to elicit language describing asthma symptoms and exacerbations and to assess understanding and relevance of draft Peds-AIRQ questions. Physicians and parents/caregivers provided clinical information and performed assessments relative to the children's asthma morbidity.</div></div><div><h3>Results</h3><div>There were 60 dyads that participated: children's mean (SD) age = 7.9 (1.9) years; 68% male, 45% non-White, 32% Hispanic, and 40% with public health insurance. Overall, 53% had well-controlled, 30% partly controlled, and 17% uncontrolled asthma, based on the Global Initiative for Asthma symptom control questions. Oral or injected corticosteroids were used for asthma by 53% of the children in the previous year. Participants found draft Peds-AIRQ items understandable and relevant. Seven impairment and 3 risk questions were retained for validation, along with 5 additional items containing wording or control threshold variations.</div></div><div><h3>Conclusion</h3><div>This study supports the need for developing a composite (impairment and risk) control tool to assess children aged 5 to 11 years with asthma and identified suitable questions for the validation of a Peds-AIRQ.</div></div>","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"134 2","pages":"Pages 198-208.e2"},"PeriodicalIF":5.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142774574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to ‘Inflammatory pathways in patients with post-acute sequelae of COVID-19’ [Annals of Allergy, Asthma & Immunology 133/5 (2024) 507 – 515] “COVID-19急性后后遗症患者的炎症途径”的勘误表[Annals of Allergy, Asthma & Immunology] 133/5(2024) 507 - 515]。
IF 5.8 2区 医学
Annals of Allergy Asthma & Immunology Pub Date : 2025-02-01 DOI: 10.1016/j.anai.2024.11.026
Matthew R. Elliott MD, Anna E. O'Connor MD, Gailen D. Marshall MD, PhD
{"title":"Corrigendum to ‘Inflammatory pathways in patients with post-acute sequelae of COVID-19’ [Annals of Allergy, Asthma & Immunology 133/5 (2024) 507 – 515]","authors":"Matthew R. Elliott MD,&nbsp;Anna E. O'Connor MD,&nbsp;Gailen D. Marshall MD, PhD","doi":"10.1016/j.anai.2024.11.026","DOIUrl":"10.1016/j.anai.2024.11.026","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"134 2","pages":"Page 243"},"PeriodicalIF":5.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142803119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Osteonecrosis: A disabling disease not to be ignored in asthma and atopic conditions 骨质疏松症:哮喘和特应性疾病中不可忽视的致残性疾病。
IF 5.8 2区 医学
Annals of Allergy Asthma & Immunology Pub Date : 2025-02-01 DOI: 10.1016/j.anai.2024.10.025
Chase P. Rupprecht MD , Guha Krishnaswamy MD
{"title":"Osteonecrosis: A disabling disease not to be ignored in asthma and atopic conditions","authors":"Chase P. Rupprecht MD ,&nbsp;Guha Krishnaswamy MD","doi":"10.1016/j.anai.2024.10.025","DOIUrl":"10.1016/j.anai.2024.10.025","url":null,"abstract":"<div><div>Osteonecrosis, also referred to as avascular necrosis, is a disease characterized by necrosis or death of a bone secondary to impairment in blood supply. The condition affects the epiphyseal ends of the bones such as the femur and the humerus, but it can also involve the metacarpal and metatarsal bones, the patella, the knee, the vertebrae, and the jaw. A plethora of inflammatory, autoimmune, hematological, thrombotic, and vascular diseases can lead to osteonecrosis. Corticosteroids are intimately linked to the development of osteonecrosis. The frequent use of systemic corticosteroids in patients with asthma, eczema, nasal polyposis, sinusitis, urticaria and angioedema, or anaphylaxis makes this disease of great relevance to the practicing allergist and pulmonologist. Untreated, bone necrosis leads to frustrated bone remodeling and angiogenesis, leading to subchondral fractures and collapse of the articular heads of the bones, and culminating in debilitating osteoarthritis, often requiring arthroplasty. Recent studies have shed light on the molecular mechanisms underlying osteonecrosis and on the role of glucocorticoids. The gold standard test in patients suspected of having the disease is magnetic resonance imaging scanning, with plain radiographs having a lower sensitivity and specificity. Early diagnosis and intervention are essential. The allergist should avoid the frequent use of glucocorticoids and consider early introduction of steroid-sparing alternatives for asthma or sinusitis. Smoking and alcohol ingestion need to be addressed, and the management of glucocorticoid-induced osteoporosis may be helpful. It is essential for allergists to familiarize themselves with the disease and its diagnosis and to consider early referral to an orthopedic surgeon for surgical intervention.</div></div>","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"134 2","pages":"Pages 165-176"},"PeriodicalIF":5.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142568098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How I diagnose IgE-mediated food allergy 临床大师:我是如何诊断 IgE 导致的食物过敏的?
IF 5.8 2区 医学
Annals of Allergy Asthma & Immunology Pub Date : 2025-02-01 DOI: 10.1016/j.anai.2024.10.027
Matthew Greenhawt MD, MBA, MSc
{"title":"How I diagnose IgE-mediated food allergy","authors":"Matthew Greenhawt MD, MBA, MSc","doi":"10.1016/j.anai.2024.10.027","DOIUrl":"10.1016/j.anai.2024.10.027","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"134 2","pages":"Pages 177-180"},"PeriodicalIF":5.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142632214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oscillometry-defined small airways dysfunction as a treatable trait in asthma 摆动测定法将小气道功能障碍定义为可治疗的哮喘特征。
IF 5.8 2区 医学
Annals of Allergy Asthma & Immunology Pub Date : 2025-02-01 DOI: 10.1016/j.anai.2024.11.006
Marcello Cottini MD , Carlo Lombardi MD , Pasquale Comberiati MD , Alvise Berti MD , Francesco Menzella MD , Ronald J. Dandurand MD , Zuzana Diamant MD, PhD , Rory Chan MBChB, PhD
{"title":"Oscillometry-defined small airways dysfunction as a treatable trait in asthma","authors":"Marcello Cottini MD ,&nbsp;Carlo Lombardi MD ,&nbsp;Pasquale Comberiati MD ,&nbsp;Alvise Berti MD ,&nbsp;Francesco Menzella MD ,&nbsp;Ronald J. Dandurand MD ,&nbsp;Zuzana Diamant MD, PhD ,&nbsp;Rory Chan MBChB, PhD","doi":"10.1016/j.anai.2024.11.006","DOIUrl":"10.1016/j.anai.2024.11.006","url":null,"abstract":"<div><div>The small airways, also referred to as the lung's silent zone, are closely associated with poor symptom control and more frequent asthma exacerbations. The oscillometry technique superimposes sound or airwaves onto normal tidal breathing and provides information on resistance and reactance, that is, obstacles to airflow occurring inside and outside of the bronchi. More recently, a management paradigm based on so-called “treatable traits” has been proposed to personalize and improve asthma care for individuals by proactively identifying and targeting modifiable pulmonary, extrapulmonary, and behavioral traits affecting asthma control. In this review article, we evaluate the literature on small airways dysfunction as a potential treatable trait in persistent asthma. In particular, we discuss whole- and intrabreath oscillometry and the impact of extrafine inhaled corticosteroids and systemic biologics on the peripheral airways.</div></div>","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"134 2","pages":"Pages 151-158"},"PeriodicalIF":5.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142644979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of diamine oxidase in the management of angioedema 二胺氧化酶在治疗血管性水肿中的作用。
IF 5.8 2区 医学
Annals of Allergy Asthma & Immunology Pub Date : 2025-02-01 DOI: 10.1016/j.anai.2024.11.011
María Carmen Díaz Donado MD, PhD , Zuelem Evelyn Danz Luque MD , Juan Majada Guijo PhD , Juan Jesús Fernández Madera MD , María Dolores Quiñones Estévez MD, PhD
{"title":"Role of diamine oxidase in the management of angioedema","authors":"María Carmen Díaz Donado MD, PhD ,&nbsp;Zuelem Evelyn Danz Luque MD ,&nbsp;Juan Majada Guijo PhD ,&nbsp;Juan Jesús Fernández Madera MD ,&nbsp;María Dolores Quiñones Estévez MD, PhD","doi":"10.1016/j.anai.2024.11.011","DOIUrl":"10.1016/j.anai.2024.11.011","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"134 2","pages":"Pages 234-236"},"PeriodicalIF":5.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142689567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Airway oscillometry in asthma 哮喘的气道振荡测量--现状与未来展望。
IF 5.8 2区 医学
Annals of Allergy Asthma & Immunology Pub Date : 2025-02-01 DOI: 10.1016/j.anai.2024.09.007
Rory Chan MBChB, PhD, Brian Lipworth MD
{"title":"Airway oscillometry in asthma","authors":"Rory Chan MBChB, PhD,&nbsp;Brian Lipworth MD","doi":"10.1016/j.anai.2024.09.007","DOIUrl":"10.1016/j.anai.2024.09.007","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"134 2","pages":"Pages 129-130"},"PeriodicalIF":5.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142300087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The paradigm shift in drug development for atopic dermatitis: Addressing the variables of the equation leading to disease modification 特应性皮炎药物研发模式的转变:解决导致疾病改变的方程式中的变量。
IF 5.8 2区 医学
Annals of Allergy Asthma & Immunology Pub Date : 2025-02-01 DOI: 10.1016/j.anai.2024.09.022
Thomas Bieber MD, PhD, MDRA
{"title":"The paradigm shift in drug development for atopic dermatitis: Addressing the variables of the equation leading to disease modification","authors":"Thomas Bieber MD, PhD, MDRA","doi":"10.1016/j.anai.2024.09.022","DOIUrl":"10.1016/j.anai.2024.09.022","url":null,"abstract":"<div><div>The recent development of new therapies for atopic dermatitis (AD) has greatly benefited from the advances in understanding the mechanisms underlying this disease. This progress now allows one to envisage pushing the therapeutic boundaries beyond the simple symptomatic treatment of the exacerbations of AD and considering new therapeutic strategies aimed to allow an off-therapy long-term and deep remission, that is, disease modification. Owing to the complexity of the phenotype and underlying mechanisms of AD, it is expected that this will not fit to the current one-size-fits-all model in drug development. Thus, aiming at disease modification will lead to a paradigm shift in drug development strategy in AD requiring the consideration of a precision medicine approach with a phenotype-endotype (biomarker)-based stratification as well as a consensus definition of specific study endpoints for the clinical development program. This review addresses the scientific rationale for this strategy, some general aspects of the design of confirmatory clinical trials, and the variables along the Population, Intervention, Comparator, and Outcome framework to be addressed for reaching the ultimate goal of disease modification in AD.</div></div>","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"134 2","pages":"Pages 144-150"},"PeriodicalIF":5.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142394992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Supraglottic Index 声门上指数:哮喘患者对喉咽反流疗法反应的指标。
IF 5.8 2区 医学
Annals of Allergy Asthma & Immunology Pub Date : 2025-02-01 DOI: 10.1016/j.anai.2024.10.012
Laurie A. Manka MD , Vamsi P. Guntur MD, MSc , Allen D. Stevens BA , Christena Kolakowski MS , Camille M. Moore PhD , Richard J. Martin MD
{"title":"The Supraglottic Index","authors":"Laurie A. Manka MD ,&nbsp;Vamsi P. Guntur MD, MSc ,&nbsp;Allen D. Stevens BA ,&nbsp;Christena Kolakowski MS ,&nbsp;Camille M. Moore PhD ,&nbsp;Richard J. Martin MD","doi":"10.1016/j.anai.2024.10.012","DOIUrl":"10.1016/j.anai.2024.10.012","url":null,"abstract":"<div><h3>Background</h3><div>Laryngopharyngeal reflux (LPR) is associated with gastroesophageal reflux and is known to cause poor asthma control. Moreover, LPR and asthma frequently coexist in the same individual. Controlling LPR could be associated with improved asthma control. The Supraglottic Index (SGI) is a clinically applied visual scale, which correlates with the presence of LPR. The role of SGI in monitoring LPR therapy in individuals with asthma is not known.</div></div><div><h3>Objective</h3><div>To determine whether the SGI can be used over time to assess the presence of LPR in patients with asthma, and whether the SGI improves with LPR treatment.</div></div><div><h3>Methods</h3><div>This is a pilot study in 15 participants with asthma. Those without evidence of LPR by SGI measurement were assigned to the observation arm. Those with LPR were assigned to the treatment arm and were treated with either standard-of-care LPR treatment (antacids and behavioral management) or a novel therapy (upper esophageal assist device).</div></div><div><h3>Results</h3><div>The SGI remained stable in individuals with asthma who underwent observation over 8 weeks. The SGI improved in participants with asthma treated for LPR (<em>P</em> = .024).</div></div><div><h3>Conclusion</h3><div>The SGI is a readily available clinical tool to assess the presence of LPR and monitor its therapy in asthma.</div></div>","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"134 2","pages":"Pages 209-214.e2"},"PeriodicalIF":5.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142479914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
“Oscillometry Associates”
IF 5.8 2区 医学
Annals of Allergy Asthma & Immunology Pub Date : 2025-02-01 DOI: 10.1016/j.anai.2024.09.004
Erin L. Reigh MD, MS
{"title":"“Oscillometry Associates”","authors":"Erin L. Reigh MD, MS","doi":"10.1016/j.anai.2024.09.004","DOIUrl":"10.1016/j.anai.2024.09.004","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"134 2","pages":"Pages 181-182"},"PeriodicalIF":5.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143158870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信